8 months ago
BMY
AnalystsLouise ChenLouise Chen's Stock Forecasts
AnalystsLouise Chen
Analyst Ranking
Top 11%
#590 out of 5511 analysts
Average Return
+5.46%
Win Rate
47%147 out of 312
Risk vs Reward
Poor
Good
Louise Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Palvella Therapeutics IncPVLA | +447.41% | $24.55 | $134.39 | 2025-03-07 - 2026-03-06 | Buy |
Cogent Biosciences IncCOGT | +428.96% | $7.01 | $37.08 | 2025-03-07 - 2026-03-06 | Buy |
Cidara Therapeutics IncCDTX | +394.17% | $12.86 | $63.55 | 2024-08-14 - 2025-08-14 | Strong Buy |
Aclaris Therapeutics IncACRS | +291.27% | $1.26 | $4.93 | 2025-05-09 - 2026-05-08 | Buy |
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-23 - 2024-03-06 | Strong Buy |
Louise Chen Analyst Color
Get additional color on Louise Chen's coverage of popular stocks
9 months ago
BMY
9 months ago
MRK
2 years ago
LLY
2 years ago
LLY
2 years ago
LLY
3 years ago
LLY
3 years ago
LLY
3 years ago
LLY
4 years ago
MRK
Louise Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Amgen IncAMGN | 1 | Buy | $450.00 | +19.57% | Maintains | a month ago |
Merck & Co IncMRK | 26 | Buy | $155.00 | +6.96% | Maintains | 3 months ago |
Teva Pharmaceutical Industries LtdTEVA | 4 | Buy | $40.00 | +3.82% | Maintains | 8 months ago |
Johnson & JohnsonJNJ | 39 | Buy | $265.00 | -0.85% | Maintains | 8 months ago |
Bristol Myers Squibb CoBMY | 2 | Hold | $60.00 | -5.66% | Maintains | 8 months ago |
Regeneron Pharmaceuticals IncREGN | 2 | Hold | $770.00 | -0.60% | Maintains | 10 months ago |
Sarepta Therapeutics IncSRPT | 3 | Buy | $80.00 | N/A | Upgrades | a year ago |
Blueprint Medicines CorpBPMC | 2 | Hold | $135.00 | N/A | Downgrades | a year ago |
Aclaris Therapeutics IncACRS | 6 | Buy | $9.00 | N/A | Maintains | a year ago |
Edgewise Therapeutics IncEWTX | 2 | Hold | $14.00 | N/A | Downgrades | a year ago |
Gain Therapeutics IncGANX | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Innoviva IncINVA | 5 | Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Ptc Therapeutics IncPTCT | 1 | Hold | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Perspective Therapeutics IncCATX | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Palvella Therapeutics IncPVLA | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Ardelyx IncARDX | 5 | Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Cogent Biosciences IncCOGT | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Avidity Biosciences IncRNAM | 1 | Buy | $70.00 | N/A | Initiates Coverage On | 2 years ago |
Dyne Therapeutics IncDYN | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Ars Pharmaceuticals IncSPRY | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Zai Lab LtdZLAB | 8 | Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Spero Therapeutics IncSPRO | 4 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Novo Nordisk A SNVO | 20 | Strong Buy | $160.00 | N/A | Reiterates | 2 years ago |
Vaxcyte IncPCVX | 6 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Abbvie IncABBV | 6 | Strong Buy | $240.00 | N/A | Maintains | 2 years ago |
Pfizer IncPFE | 31 | Strong Buy | $45.00 | N/A | Reiterates | 2 years ago |
Zevra Therapeutics IncZVRA | 5 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Roivant Sciences LtdROIV | 9 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Eli Lilly & CoLLY | 44 | Strong Buy | $885.00 | N/A | Reiterates | 2 years ago |
Evolus IncEOLS | 4 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Immunovant IncIMVT | 10 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Mesoblast LtdMESO | 6 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Lyra Therapeutics IncLYRA | 3 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Cidara Therapeutics IncCDTX | 6 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Atossa Therapeutics IncATOS | 3 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Adlai Nortye Group LtdANL | 2 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Amarin Corp PLCAMRN | 2 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Pds Biotechnology CorpPDSB | 2 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Scynexis IncSCYX | 3 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Buy | $65.00 | N/A | Reiterates | 3 years ago |
Ambrx Biopharma IncAMAM | 4 | Strong Buy | $25.00 | N/A | Reiterates | 3 years ago |
Connect Biopharma Holdings LtdCNTB | 2 | Strong Buy | $5.00 | N/A | Reiterates | 3 years ago |
Novabridge BiosciencesNBP | 4 | Strong Buy | $25.00 | N/A | Reiterates | 3 years ago |
Hutchmed LtdHCM | 3 | Strong Buy | $50.00 | N/A | Reiterates | 3 years ago |
Gracell Biotechnologies IncGRCL | 3 | Strong Buy | $20.00 | N/A | Reiterates | 3 years ago |
Arcutis Biotherapeutics IncARQT | 3 | Strong Buy | $50.00 | N/A | Reiterates | 3 years ago |
Aravive IncARAV | 7 | Hold | $0.25 | N/A | Downgrades | 3 years ago |
Therapeuticsmd IncTXMD | 4 | Hold | $5.00 | N/A | Reiterates | 3 years ago |
Yarrow Bioscience IncYARW | 1 | Strong Buy | $450.00 | N/A | Maintains | 3 years ago |
Cutera IncCUTRQ | 3 | Hold | $21.00 | N/A | Maintains | 3 years ago |
Humanigen IncHGENQ | 3 | Hold | $0.15 | N/A | Reinstates | 4 years ago |
Contrafect CorpCFRXQ | 2 | Hold | $80.00 | N/A | Downgrades | 4 years ago |
Entasis Therapeutics Holdings IncETTX | 2 | Hold | $2.00 | N/A | Downgrades | 4 years ago |
Rvl Pharmaceuticals PLCRVLPQ | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 5 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Effector Therapeutics IncEFTR | 1 | Strong Buy | $1,250.00 | N/A | Initiates Coverage On | 5 years ago |
Jaguar Health IncJAGX | 1 | Strong Buy | $885,937,500.00 | N/A | Initiates Coverage On | 5 years ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 5 years ago |
Soliton IncSOLY | 2 | Hold | $22.60 | N/A | Downgrades | 5 years ago |
Factset Research Systems IncFDS | 1 | Hold | $258.00 | N/A | Maintains | 6 years ago |
Endo International PLCENDPQ | 2 | Hold | $18.00 | N/A | Maintains | 8 years ago |
Heron Therapeutics IncHRTX | 1 | Strong Buy | $50.00 | N/A | Maintains | 8 years ago |
Allergan PLCAGN | 1 | Hold | $180.00 | N/A | Maintains | 8 years ago |
Impax Laboratories IncIPXL | 2 | Strong Buy | $35.00 | N/A | Maintains | 9 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Strong Buy | $44.00 | N/A | Initiates Coverage On | 9 years ago |
Opko Health IncOPK | 2 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 9 years ago |
Neos Therapeutics IncNEOS | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 9 years ago |
Revance Therapeutics IncRVNC | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 9 years ago |
Dermira IncDERM2 | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.